{"id":138691,"date":"2026-05-08T08:58:09","date_gmt":"2026-05-08T08:58:09","guid":{"rendered":"https:\/\/indogenmed.org\/product\/ocupol-dx-5-ml-tablets\/"},"modified":"2026-08-27T20:00:36","modified_gmt":"2026-08-27T20:00:36","slug":"ocupol-dx-5-ml-tablets","status":"publish","type":"product","link":"https:\/\/indogenmed.org\/fr\/product\/ocupol-dx-5-ml-tablets\/","title":{"rendered":"Ocupol Dx 5 Ml"},"content":{"rendered":"

Ocupol Dx 5 Ml Tablets (Chloramphenicol IP): Clinical Profile, Uses, Dosage, and Safety<\/h1>\n

Ocupol Dx 5 Ml Tablets<\/strong> is a prescription product containing Chloramphenicol IP<\/strong>. It is used in clinically selected treatment pathways and should be used only under professional supervision. This page summarizes core product facts to support informed discussions with licensed healthcare professionals.<\/p>\n

Safe use depends on diagnosis, formulation, route, dose, and duration. For this reason, the sections below provide a structured profile aligned with clinical documentation standards for pharmaceutical education and patient counseling.<\/p>\n

Introduction<\/h2>\n

Ocupol Dx 5 Ml Tablets is a ophthalmic solution manufactured by Centaur Pharmaceuticals Pvt. Ltd<\/strong>. It is positioned within the antibiotic class and prescribed for condition-specific clinical goals. Treatment planning should always follow clinician judgment and local labeling.<\/p>\n

Patients should verify product identity, strength, and route every time a medicine is dispensed. Similar brand names may represent different ingredients, and substitutions require clinician or pharmacist confirmation.<\/p>\n

1. Product Overview \/ Clinical Profile<\/h2>\n
    \n
  • Brand Name:<\/strong> Ocupol Dx 5 Ml Tablets<\/li>\n
  • Active Ingredient:<\/strong> Chloramphenicol IP<\/li>\n
  • Manufacturer:<\/strong> Centaur Pharmaceuticals Pvt. Ltd<\/li>\n
  • Dosage Form:<\/strong> ophthalmic solution<\/li>\n
  • Therapeutic Category:<\/strong> antibiotic<\/li>\n<\/ul>\n

    2. Mechanism of Action (MOA)<\/h2>\n

    Ocupol Dx 5 Ml Tablets acts through Chloramphenicol IP, an antibacterial mechanism that inhibits key microbial growth pathways and supports clearance of susceptible infections when used at the prescribed dose and duration.<\/p>\n

    Mechanistic understanding helps explain prescribing rationale, expected response timelines, and monitoring requirements. For antimicrobials, susceptibility patterns and resistance risk are central. For chronic therapies, adherence and follow-up trends are key determinants of outcomes.<\/p>\n

    MOA should always be interpreted in context: pharmacology defines potential effect, but real-world response depends on diagnosis quality, adherence, interacting medicines, and patient-specific comorbidity burden.<\/p>\n

    3. Therapeutic Indications<\/h2>\n

    Ocupol Dx 5 Ml Tablets is typically used for bacterial conjunctivitis and related susceptible ocular infections. Final indication should match approved labeling, clinician judgment, and patient-specific risk profile.<\/p>\n

      \n
    • Use only for the indication selected by a licensed prescriber.<\/li>\n
    • Avoid self-initiating or extending treatment duration without clinical review.<\/li>\n
    • Reassessment is needed if expected improvement does not occur within the expected clinical window.<\/li>\n<\/ul>\n

      Clinical teams may adjust treatment based on severity, prior therapy exposure, interaction profile, and objective response monitoring. The aim is benefit with minimized avoidable risk.<\/p>\n

      4. Dosage and Administration<\/h2>\n

      General dosing guidance: 5 ml tablets, or as directed by the prescriber.<\/p>\n

      Exact schedules vary by diagnosis and patient profile. Prescribed instructions on timing, route, duration, and technique should be followed precisely.<\/p>\n

        \n
      • Use exactly as directed by the prescriber.<\/li>\n
      • Do not skip doses or double up missed doses unless advised.<\/li>\n
      • If ophthalmic, avoid touching the dropper or tube tip to any surface.<\/li>\n
      • If injectable, follow sterile handling and storage requirements.<\/li>\n
      • Ask the clinician for written missed-dose guidance at initiation.<\/li>\n<\/ul>\n

        L’administration du mat\u00e9riel influence les r\u00e9sultats. Le bon moment, la voie d’administration et le stockage sont souvent aussi importants que le choix de la classe de m\u00e9dicament.<\/p>\n

        5. Profil de s\u00e9curit\u00e9 et pr\u00e9cautions<\/h2>\n

        Les profils d’effets ind\u00e9sirables varient selon l’ingr\u00e9dient actif et la classe. Les patients doivent examiner les contre-indications, l’historique d’allergies, les pr\u00e9occupations li\u00e9es \u00e0 la fonction des organes et les risques d’interactions avant la premi\u00e8re utilisation. Les sympt\u00f4mes persistants, s\u00e9v\u00e8res ou inattendus n\u00e9cessitent une \u00e9valuation m\u00e9dicale imm\u00e9diate.<\/p>\n

        Les principales pr\u00e9cautions comprennent le respect de la dur\u00e9e prescrite, l’\u00e9vitement d’une escalade de dose non surveill\u00e9e et le signalement pr\u00e9coce d’une mauvaise r\u00e9ponse. Pour les produits ophtalmiques, l’hygi\u00e8ne et le contr\u00f4le de la contamination sont critiques. Pour les agents syst\u00e9miques, une surveillance de laboratoire p\u00e9riodique peut \u00eatre requise chez les patients \u00e0 risque \u00e9lev\u00e9.<\/p>\n

        Consultez imm\u00e9diatement les soins d’urgence en cas d’hypersensibilit\u00e9 s\u00e9v\u00e8re, de difficult\u00e9s respiratoires, d’\u0153d\u00e8me progressif, de changements soudains de la vision, de sympt\u00f4mes thoraciques ou d’autres signes de d\u00e9t\u00e9rioration aigu\u00eb.<\/p>\n

        Stockage et manipulation<\/h2>\n

        Conservez les m\u00e9dicaments conform\u00e9ment aux instructions de l’\u00e9tiquetage officiel. Gardez les produits dans leur emballage d’origine, \u00e0 l’abri de la chaleur et de l’humidit\u00e9, et hors de port\u00e9e des enfants. Les produits ophtalmiques doivent rester bien ferm\u00e9s et exempts de contamination ; les injectables peuvent n\u00e9cessiter un contr\u00f4le strict de la temp\u00e9rature.<\/p>\n

        \u00c9liminez les produits expir\u00e9s ou endommag\u00e9s. Si un r\u00e9cipient semble endommag\u00e9 ou contamin\u00e9, reportez son utilisation jusqu’\u00e0 ce qu’un pharmacien ou un clinicien confirme qu’il est appropri\u00e9.<\/p>\n

        Suivi clinique et points de conseil<\/h2>\n

        Le suivi doit \u00e9valuer la r\u00e9ponse th\u00e9rapeutique, la tol\u00e9rance et l’observance. Les patients doivent tenir \u00e0 jour leur liste de m\u00e9dicaments et signaler l’utilisation de produits non prescrits pour \u00e9viter les risques d’interaction. Cette page est \u00e0 titre \u00e9ducatif et ne remplace pas un diagnostic ou un plan de traitement individualis\u00e9.<\/p>\n

        Lorsque cela est pertinent, les cliniciens peuvent aligner le traitement avec la gestion des antimicrobiens, les protocoles de maladies chroniques et les voies sp\u00e9cialis\u00e9es pour pr\u00e9server l’efficacit\u00e9 \u00e0 long terme et r\u00e9duire les r\u00e9sultats ind\u00e9sirables \u00e9vitables.<\/p>\n

        Le conseil m\u00e9dicamenteux doit inclure des \u00e9tapes pratiques de manipulation, la conduite \u00e0 tenir en cas de dose oubli\u00e9e, les signes d’alerte des effets ind\u00e9sirables et les moments o\u00f9 une escalade imm\u00e9diate est requise. Pour les affections chroniques, la continuit\u00e9 des soins et les visites de suivi r\u00e9guli\u00e8res sont essentielles pour ajuster les doses et g\u00e9rer les risques \u00e0 long terme.<\/p>\n

        Les aidants et les patients doivent \u00e9galement \u00eatre inform\u00e9s d’\u00e9viter le partage des m\u00e9dicaments, d’\u00e9viter toute prolongation non surveill\u00e9e du traitement et de v\u00e9rifier l’opportunit\u00e9 d’un renouvellement lorsque les sympt\u00f4mes reviennent. La r\u00e9currence peut indiquer un diagnostic diff\u00e9rent et n\u00e9cessite une r\u00e9\u00e9valuation plut\u00f4t qu’une utilisation automatique r\u00e9p\u00e9t\u00e9e.<\/p>\n

        Avis m\u00e9dical :<\/strong> Ce contenu est fourni \u00e0 titre informatif uniquement. Ne vous auto-m\u00e9dicaments. Consultez toujours un professionnel de sant\u00e9 pour un diagnostic et un traitement.<\/div>\n","protected":false},"excerpt":{"rendered":"

        Ocupol Dx 5 Ml Tablets (Chloramphenicol IP): Clinical Profile, Uses, Dosage, and Safety Ocupol Dx 5 Ml Tablets is a prescription product containing Chloramphenicol IP. It is used in clinically selected treatment pathways and should be used only under professional supervision. This page summarizes core product facts to support informed discussions with licensed healthcare professionals. […]<\/p>\n","protected":false},"featured_media":0,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[11042],"product_cat":[16254],"product_tag":[16836,16682],"igm_manufacturer":[],"class_list":["post-138691","product","type-product","status-publish","product_brand-ocupol","product_cat-mens-health-wellness","product_tag-eye-drops","product_tag-vial-bottle","pa_brand-name-ocupol-dx","pa_molecule-dexamethasone","pa_molecule-tobramycin","first","instock","sale","shipping-taxable","purchasable","product-type-simple"],"_links":{"self":[{"href":"https:\/\/indogenmed.org\/fr\/wp-json\/wp\/v2\/product\/138691","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/indogenmed.org\/fr\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/indogenmed.org\/fr\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/indogenmed.org\/fr\/wp-json\/wp\/v2\/comments?post=138691"}],"wp:attachment":[{"href":"https:\/\/indogenmed.org\/fr\/wp-json\/wp\/v2\/media?parent=138691"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/indogenmed.org\/fr\/wp-json\/wp\/v2\/product_brand?post=138691"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/indogenmed.org\/fr\/wp-json\/wp\/v2\/product_cat?post=138691"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/indogenmed.org\/fr\/wp-json\/wp\/v2\/product_tag?post=138691"},{"taxonomy":"igm_manufacturer","embeddable":true,"href":"https:\/\/indogenmed.org\/fr\/wp-json\/wp\/v2\/igm_manufacturer?post=138691"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}